Pharmaceutical Information |
Drug Name |
Iothalamic acid |
Drug ID |
BADD_D01184 |
Description |
Iothalamic acid is an iodine containing organic anion used as a diagnostic contrast agent. |
Indications and Usage |
Conray is indicated for use in excretory urography, cerebral angiography, peripheral arteriography, venography, arthrography, direct cholangiography, endoscopic retrograde cholangiopancreatography, contrast enhancement of computed tomographic brain images, cranial computerized angiotomography, intravenous digital subtraction angiography and arterial digital subtraction angiography.
Conray may also be used for enhancement of computed tomographic scans performed for detection and evaluation of lesions in the liver, pancreas, kidneys, abdominal aorta, mediastinum, abdominal cavity and retroperitoneal space. |
Marketing Status |
approved |
ATC Code |
V08AA04 |
DrugBank ID |
DB09133
|
KEGG ID |
D01258
|
MeSH ID |
D007483
|
PubChem ID |
3737
|
TTD Drug ID |
D02KCV
|
NDC Product Code |
52134-0503 |
UNII |
16CHD79MIX
|
Synonyms |
Iothalamic Acid | Acid, Iothalamic | Methalamic Acid | Acid, Methalamic | Iotalamic Acid | Acid, Iotalamic | Conray 420 | Iodothalamate | Sodium Iothalamate | Iothalamate, Sodium | Iothalamic Acid, Monosodium Salt | Iothalamic Acid, Calcium (2:1) Salt | Iothalamic Acid, Monosilver (1+) Salt | Iothalamic Acid, Monosodium Salt, Dimer | Lopamidol | Angio-Conray | Angio Conray | AngioConray | Iothalamate |
|
Chemical Information |
Molecular Formula |
C11H9I3N2O4 |
CAS Registry Number |
2276-90-6 |
SMILES |
CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)C(=O)NC)I |
Chemical Structure |
|
|
ADRs Induced by Drug |
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|